文献速递免疫规划传染病防控与疫情报告

伤寒结合疫苗保护效果评估中检测阴性设计的有效性:基于整群随机对照试验数据比较不同研究设计的估计值

The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.
PubMed 文献 · Lancet Glob Health · 2025-04-16

本研究利用孟加拉国TyVAC整群随机对照试验数据,比较整群随机对照试验、队列研究和检测阴性设计(TND)估计伤寒结合疫苗(TCV)保护效果的结果。整群随机对照试验分析疫苗有效性为89%(95%CI 81-93),队列设计为79%(70-86),TND以泛阴性为对照时为88%(79-93),以非伤寒沙门菌阳性标本为对照时为90%(75-96)。阴性对照暴露和阴性对照结局分析提示队列设计可能存在未测量的混杂,而TND提供可靠估计。

要点

  • 在TyVAC孟加拉国试验再分析中,TND估计的TCV有效性(88%-90%)与整群随机对照试验(89%)接近。
  • 队列设计估计的TCV有效性为79%,低于整群随机对照试验的89%。
  • 阴性对照分析提示队列设计可能存在未测量的混杂,如就医行为。

核心结论

  • 检测阴性设计(TND)可提供可靠的TCV有效性估计,而队列设计可能因未测量的混杂因素(如就医行为)使疫苗有效性估计产生偏倚。
  • 阴性对照暴露和阴性对照结局分析是识别此类偏倚的有用工具。

研究设计与样本

  • 研究再分析TyVAC孟加拉国试验数据,该试验为参与者盲法和观察者盲法的整群随机对照试验,在孟加拉国达卡米尔普尔开展。
  • 150个地理集群按1:1随机分配接种TCV或日本脑炎疫苗,9月龄至15岁合格儿童接种其居住集群随机分配的疫苗,基线接种于2018年4月15日至5月15日完成。
  • 比较整群随机对照试验分析、队列研究和检测阴性病例对照研究(TND)设计的疫苗有效性估计,并开展阴性对照暴露(NCE)和阴性对照结局(NCO)分析作为偏倚指标。

主要发现

  • 研究区域62 025名年龄合格儿童中,41 344名(67%)在基线接种活动中接种了TCV或日本脑炎疫苗;被动监测收集5582份血培养标本,其中2546份(46%)来自75个TCV集群。
  • 整群随机对照试验分析的疫苗有效性为89%(95%CI 81-93),队列设计为79%(70-86),TND以泛阴性为对照时为88%(79-93),TND以非伤寒沙门菌阳性标本为对照时为90%(75-96)。
  • NCE分析中,队列设计显示日本脑炎疫苗接种与伤寒风险增加相关(发病率比1.98 [95%CI 1.56-2.52]),而TND未发现日本脑炎疫苗接种与伤寒的显著关联。
  • NCO分析中,队列设计显示日本脑炎疫苗集群和TCV集群中接种者较未接种者非伤寒感染风险增加,而TND的NCO分析未观察到。

临床怎么用

  • 作者认为TND可提供可靠的TCV有效性估计,而队列设计可能因未测量的混杂(如就医行为)使估计产生偏倚。
  • 作者认为NCE和NCO方法是识别此类偏倚的有用工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Typhoid fever remains a substantial public health challenge in low-income and middle-income countries. By 2023, typhoid conjugate vaccines (TCVs) had been introduced in six countries globally, with more than 50 million doses distributed. Now that TCVs are being deployed, there is a need for observational studies to assess vaccine effectiveness in the field. We aimed to evaluate the validity of different observational study designs in estimating vaccine protection. METHODS: We compared different observational and experimental study designs for assessing vaccine effectiveness by re-analysing data from the TyVAC Bangladesh trial, a participant-blinded and observer-blinded cluster-randomised controlled trial done in Mirpur, Dhaka, Bangladesh. 150 geographical clusters were randomly assigned (1:1) to receive either TCV or Japanese encephalitis vaccine. Eligible children aged 9 months to 15 years were offered a single dose of the vaccine randomly assigned to their cluster of residence, and baseline vaccination was done between April 15 and May 15, 2018. We compared estimates of vaccine effectiveness from the cluster-randomised controlled trial analysis-which assessed the risk of blood-culture-confirmed typhoid fever among recipients of TCV versus recipients of Japanese encephalitis vaccine-with estimates from cohort study and test-negative case-control study design (TND) analyses, which compared recipients of TCV with non-vaccinees in the 75 geographical clusters where TCV was administered. We further conducted negative-control exposure (NCE) and negative-control outcome (NCO) analyses as bias indicators. FINDINGS: 41 344 (67%) of 62 025 age-eligible children in the study area received the TCV or Japanese encephalitis vaccine during the baseline vaccination campaign. Among the 62 025 age-eligible children, 5582 blood-culture specimens were collected by passive surveillance, including 2546 (46%) specimens from the 75 TCV clusters. The estimated vaccine efficacy was 89% (95% CI 81-93) in the cluster-randomised controlled trial analysis, 79% (70-86) by the cohort design, 88% (79-93) by the TND when pan-negatives were used as test-negative controls, and 90% (75-96) by the TND when specimens positive for pathogens other than Salmonella enterica serotype Typhi were used as test-negative controls. Using NCE analysis, Japanese encephalitis vaccination was associated with an increased risk of typhoid fever compared with non-vaccinees in the 75 Japanese encephalitis clusters in the cohort design (incidence rate ratio 1·98 [95% CI 1·56-2·52]), but no significant association between Japanese encephalitis vaccination and typhoid fever was found with the TND. Similarly, an increased risk of non-typhoid infections was observed in the cohort NCO analyses when comparing vaccinees with non-vaccinees in both Japanese encephalitis vaccine clusters and TCV clusters, but not in the TND NCO analyses. INTERPRETATION: Our findings suggests that the TND provides reliable estimates of TCV effectiveness, whereas the cohort design can bias vaccine effectiveness estimates, possibly due to unmeasured confounding effects, such as health-care-seeking behaviours. NCE and NCO approaches are useful tools for identifying such biases. FUNDING: The Bill & Melinda Gates Foundation.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Feng S, Zhang Y, Khanam F, et al. The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial. Lancet Glob Health. 2025. PMID: 40252689. doi:10.1016/S2214-109X(25)00056-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。